Skip to main content
Caplight Logo









Bionic Vision Technologies

Bionic Vision Technologies

Private
MelbourneHealthcare & Life Scienceshttps://bionicvisiontech.com/

Last Round

Grant

Jul 20, 2020

Total Funding Raised

$18.73M

Company Overview

Bionic Vision Technologies is a biotechnology company that develops suprachoroidal retinal prostheses designed to restore functional vision to individuals with inherited retinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Application

Keywords

retinal prosthesisbionic eyemedical devicevision restorationsuprachoroidal implantretinitis pigmentosavision processingneuroprostheticsbrain-computer interfaceBCIimplantable electronicsassistive technologybiotechmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bionic Vision Technologies Comparables

Compare Bionic Vision Technologies with similar companies based on industry and business-model similarity.

Bionic Vision Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iBionics Inc.
86%
Iridium Medical Technology Co., Ltd.
84%
Vivani Medical
83%

Bionic Vision Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 20, 2020
Series AMar 15, 2017

Bionic Vision Technologies Investors

Notable investors and investment history

Bionic Vision Technologies investors
InvestorRounds
University of MelbourneSeries A
Western Sydney UniversitySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2020

    $730K grant received from health-gov.

Bionic Vision Technologies Filings

Explore SEC and related filing metadata, where available.

Bionic Vision Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bionic Vision Technologies's valuation, stock price, and market status.

Is Bionic Vision Technologies a public or private company?

Bionic Vision Technologies is a private company.

What is the current stock price of Bionic Vision Technologies?

Bionic Vision Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is Bionic Vision Technologies worth (valuation)?

Valuation information for Bionic Vision Technologies is not publicly available.

Can I buy Bionic Vision Technologies stock?

Bionic Vision Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bionic Vision Technologies's last funding round?

Bionic Vision Technologies's most recent funding round was Grant on July 20, 2020.

Who are the main investors in Bionic Vision Technologies?

Key investors in Bionic Vision Technologies include University of Melbourne, Western Sydney University.

Will Bionic Vision Technologies IPO soon?

No public IPO plans have been announced for Bionic Vision Technologies.

How can I track Bionic Vision Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bionic Vision Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMelbourne
Year Founded2010
Last FundingJul 20, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?